Ysios Capital Founded 2008
Founders Joel Jean Mairet
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 25
Rounds per year 1.92
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.34
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Venture
Areas of investment
Asset Management
Finance
Financial Services
Summary

Ysios Capital appeared to be the VC, which was created in 2008. The fund was located in Europe if to be more exact in Spain. The main department of described VC is located in the Barcelona.

The fund was created by Joel Jean Mairet. Besides them, we counted 6 critical employees of this fund in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Ysios Capital works on 6 percentage points less the average amount of lead investments. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Ysios Capital, startups are often financed by Kurma Partners, Caixa Capital Risc, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Life Sciences Partners, Idinvest Partners, Andera Partners. In the next rounds fund is usually obtained by Caixa Capital Risc, Kurma Partners, Gilde Healthcare.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Among the most popular fund investment industries, there are Medical, Hospital. Among the various public portfolio startups of the fund, we may underline CVRx, AM Pharma, BioVex The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Rainier Therapeutics
Biopharma
Biotechnology
Developer Platform
Medical
Therapeutics
Series B
20M09 May 2018 United States, San Leandro
Xeltis
Health Care
Medical Device
Therapeutics
Series C
45M15 Nov 2017 Switzerland, Zurich
Aelix Therapeutics
Biotechnology
Health Care
Therapeutics
Series A
11M11 Jan 2016 Spain, Barcelona
Endosense
Biotechnology
Health Care
Medical Device
Surgical Devices
Therapeutics
Series C
39M27 Nov 2013 Switzerland, Geneva
Anaconda BioMed
Health Care
Hospital
Medical
Medical Device
Series A
15M22 May 2017 Spain, Barcelona
STAT-Dx
Biotechnology
Health Care
Health Diagnostics
Series B
22M06 May 2013 Spain, Barcelona
VarmX
Manufacturing
Pharmaceutical
Therapeutics
Series B
37M08 Jul 2020 Netherlands, Leiden
STAT-Dx
Biotechnology
Health Care
Health Diagnostics
Series C
29M10 Apr 2016 Spain, Barcelona
Cellerix
Biotechnology
Medical
Pharmaceutical
Series C
37M28 Jan 2010 Spain, Madrid
SparingVision
Biotechnology
Life Science
Venture - Series Unknown
52M21 Oct 2020 France, Paris
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ysios Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: